✦ LIBER ✦

Feasibility and Toxicity of Concomitant Radio/Immunotherapy with MabThera (Rituximab®) for Patients with Non-Hodkin's Lymphoma

✍ Scribed by Alfred Haidenberger*; Sabine Fromm-Haidenberger*; Alexander de Vries; Bela-Andre Popper; Michael Steurer; Ira Skvortsova; Johanna Kantner; Eberhard Gunsilius; Peter Lukas

Book ID: 105776912
Publisher: Springer
Year: 2011
Tongue: German
Weight: 277 KB
Volume: 187
Category: Article
ISSN: 0179-7158
DOI: 10.1007/s00066-011-2169-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent administration of high-dose c

Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma

✍ Ladetto, M; Zallio, F; Vallet, S; Ricca, I; Cuttica, A; Caracciolo, D; Corradini 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 151 KB

PCN69 Cost-Effectiveness Analysis of Mai

PCN69 Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab (MabThera) for Non-Hodgkins Lymphoma Patients in Greece, a Local Adaptation

✍ F. Demousis; A. Athanasiadis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

IDEC-C2B8 anti-CD20 (Rituximab) immunoth

IDEC-C2B8 anti-CD20 (Rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients

✍ D.T. Nguyen; J. A. Amess; H. Doughty; L. Hendry; L.W. Diamond 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 766 KB

The Cost-Effectiveness of Bendamustine-R

The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in Mexico

✍ Bertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

The Cost-Effectiveness of Bendamustine-R

✍ Bertwistle, D.; Munakata, J.; Wehler, E; Leyva, V.; Ariza, J.G.; Zambrano, C.; G 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Fludarabine, cyclophosphamide, and ritux

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-hodgkin lymphoma

✍ Constantine S. Tam; Max Wolf; H. Miles Prince; E. Henry Januszewicz; David Weste 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views